Mark L. Barr

9.3k total citations · 1 hit paper
137 papers, 6.2k citations indexed

About

Mark L. Barr is a scholar working on Surgery, Transplantation and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark L. Barr has authored 137 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Surgery, 49 papers in Transplantation and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark L. Barr's work include Transplantation: Methods and Outcomes (68 papers), Organ Transplantation Techniques and Outcomes (40 papers) and Renal Transplantation Outcomes and Treatments (33 papers). Mark L. Barr is often cited by papers focused on Transplantation: Methods and Outcomes (68 papers), Organ Transplantation Techniques and Outcomes (40 papers) and Renal Transplantation Outcomes and Treatments (33 papers). Mark L. Barr collaborates with scholars based in United States, Canada and United Kingdom. Mark L. Barr's co-authors include Vaughn A. Starnes, Felicia A. Schenkel, Robbin G. Cohen, Rainer W.G. Gruessner, Winfield J. Wells, Alan B. Leichtman, Gordon D. Wu, Eric A. Rose, H.-U. Meier-Kriesche and Rami Bustami and has published in prestigious journals such as New England Journal of Medicine, Circulation and Nature Medicine.

In The Last Decade

Mark L. Barr

134 papers receiving 6.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunosuppression: Evolution in Practice and Trends, 1994–2004

2006 434 citations Mark L. Barr et al. American Journal of Transplantation profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Mark L. Barr	3.3k	1.6k	1.1k	851	763	137	6.2k
John H. Dark	5.6k 1.7×	1.4k 0.9×	2.4k 2.1×	354 0.4×	802 1.1×	278	7.7k
Nicholas R. Banner	3.9k 1.2×	1.3k 0.8×	556 0.5×	677 0.8×	1.8k 2.3×	204	6.3k
Jeffrey D. Hosenpud	3.7k 1.1×	1.1k 0.7×	987 0.9×	402 0.5×	2.0k 2.6×	97	5.4k
James F. Burdick	2.1k 0.6×	2.0k 1.3×	1.1k 1.0×	434 0.5×	312 0.4×	142	5.2k
J. Wallwork	6.2k 1.9×	1.6k 1.0×	3.0k 2.6×	619 0.7×	1.9k 2.4×	296	9.5k
Mark A. Hardy	2.9k 0.9×	1.9k 1.2×	455 0.4×	465 0.5×	342 0.4×	259	6.1k
A. Osama Gaber	4.3k 1.3×	3.4k 2.2×	837 0.7×	802 0.9×	283 0.4×	366	8.9k
Vaughn A. Starnes	3.8k 1.1×	653 0.4×	2.3k 2.1×	709 0.8×	1.6k 2.1×	232	6.6k
Yasuhiro Ogura	3.6k 1.1×	859 0.5×	508 0.5×	1.0k 1.2×	364 0.5×	247	7.5k
Andreas Zuckermann	6.2k 1.9×	2.9k 1.8×	795 0.7×	576 0.7×	2.0k 2.7×	290	8.3k

Countries citing papers authored by Mark L. Barr

Since Specialization

Citations

This map shows the geographic impact of Mark L. Barr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Barr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Barr more than expected).

Fields of papers citing papers by Mark L. Barr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Barr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Barr. The network helps show where Mark L. Barr may publish in the future.

Co-authorship network of co-authors of Mark L. Barr

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Barr. A scholar is included among the top collaborators of Mark L. Barr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Barr. Mark L. Barr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rajeev, Nithya, et al.. (2025). Evaluation of hemolysis in patients supported with Impella 5.5: a single center experience. Journal of Cardiothoracic Surgery. 20(1). 143–143.

Tatum, James M., Michael E. Bowdish, Wendy J. Mack, et al.. (2017). Outcomes after mitral valve repair: A single-center 16-year experience. Journal of Thoracic and Cardiovascular Surgery. 154(3). 822–830.e2. 21 indexed citations

Ganesh, Sivagini, et al.. (2013). Takotsubo Cardiomyopathy in a Heart Transplant Recipient. CHEST Journal. 144(4). 124A–124A. 2 indexed citations

Yusen, Roger D., Tempie H. Shearon, Yushen Qian, et al.. (2010). Lung Transplantation in the United States, 1999-2008. American Journal of Transplantation. 10(4). 1047–1068. 113 indexed citations

Barr, Mark L., et al.. (2007). Living Lobar Lung Transplantation. Operative Techniques in Thoracic and Cardiovascular Surgery. 12(1). 47–56. 3 indexed citations

Kawut, Steven M., David J. Lederer, Shaf Keshavjee, et al.. (2007). Outcomes after Lung Retransplantation in the Modern Era. American Journal of Respiratory and Critical Care Medicine. 177(1). 114–120. 86 indexed citations

Cramer, Donald V., et al.. (2005). Transforming Growth Factor-β/Interleukin-2–induced Regulatory CD4+ T Cells Prolong Cardiac Allograft Survival in Rats. The Journal of Heart and Lung Transplantation. 24(12). 2153–2159. 9 indexed citations

Barr, Mark L., Felicia A. Schenkel, Michael E. Bowdish, & V. A. Starnes. (2005). Living Donor Lobar Lung Transplantation: Current Status and Future Directions. Transplantation Proceedings. 37(9). 3983–3986. 17 indexed citations

Bowdish, Michael E., Mark L. Barr, Felicia A. Schenkel, et al.. (2004). A Decade of Living Lobar Lung Transplantation: Perioperative Complications after 253 Donor Lobectomies. American Journal of Transplantation. 4(8). 1283–1288. 42 indexed citations

10.

Wu, Gordon D., Jan A. Nolta, Mark L. Barr, et al.. (2003). Migration of mesenchymal stem cells to heart allografts during chronic rejection. Transplantation. 75(5). 679–685. 143 indexed citations

11.

Barr, Mark L., Craig Baker, Felicia A. Schenkel, et al.. (2001). Living donor lung transplantation: selection, technique, and outcome. Transplantation Proceedings. 33(7-8). 3527–3532. 31 indexed citations

12.

Marboe, Charles C., et al.. (1999). Sirolimus (rapamycin) potentiates cyclosporine in prevention of acute lung rejection. Journal of Thoracic and Cardiovascular Surgery. 117(4). 714–718. 18 indexed citations

13.

Carey, Joseph, et al.. (1999). A COMPARISON OF THE NEW PRESERVATION SOLUTION CELSIOR TO EURO-COLLINS AND UNIVERSITY OF WISCONSIN SOLUTIONS IN LUNG REPERFUSION INJURY1. Transplantation. 67(1). 152–155. 43 indexed citations

14.

Taylor, David O., Mark L. Barr, Branislav Radovančević, et al.. (1999). A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus11This study was sponsored by a grant from Fujisawa USA, Deerfield, Illinois.22The authors were working on behalf of the Tacrolimus US Heart Transplant Multicenter Study Group. Other members of the Study Group included (principal investigator listed first): UTAH Cardiac Transplant Program, Salt Lake City, Utah: David O. Taylor, MD, Dale G. Renlund, MD, Abdallah G. Kfoury, MD; St. Luke’s Episcopal Hospital/Texas Heart Institute, Houston, Texas: O. H. Frazier, MD, Branislav Radovancevic, MD, Edward K. Massin, MD; University of Wisconsin Hospitals and Clinics, Madison, Wisconsin: Robert M. Mentzer, Jr., MD, Charles C. Canver, MD, Robert B. Love, MD; Ochsner Medical Foundation, New Orleans, Louisiana: Frank W. Smart, MD, Hector O. Ventura, MD, Dwight D. Stapleton, MD, Mandeep Mehra, MD; University of Southern California, Los Angeles, California: Mark L. Barr, MD, Vaugh A. Starnes, MD; Medical College of Virginia, Richmond, Virginia: David E. Tolman, MD, Albert Guerraty, MD, David Salter, MD; Cleveland Clinic Foundation, Cleveland, Ohio: James B. Young, MD; Data Management and Statistical Coordinating Center-The EMMES Corporation, Potomac, Maryland: Paul VanVeldhuisen, MS, Anne Lindblad, PhD, Anita Yaffe, MSN, MPH.. The Journal of Heart and Lung Transplantation. 18(4). 336–345. 213 indexed citations

15.

Carey, Joseph, et al.. (1998). Addition of aprotinin to organ preservation solutions decreases lung reperfusion injury. The Annals of Thoracic Surgery. 66(1). 225–230. 36 indexed citations

16.

Barr, Mark L.. (1996). Immunomodulation in Transplantation with Photopheresis. Artificial Organs. 20(8). 971–973. 16 indexed citations

17.

Michler, Robert E., Mike J. McLaughlin, Jonathan M. Chen, et al.. (1993). Clinical experience with cardiac retransplantation. Journal of Thoracic and Cardiovascular Surgery. 106(4). 622–631. 24 indexed citations

18.

Ensley, R D, Sharon Hunt, David O. Taylor, et al.. (1992). Predictors of survival after repeat heart transplantation. The Journal of Heart and Lung Transplantation. 11. 40 indexed citations

19.

Jeevanandam, Valluvan, Mark L. Barr, Juan A. Sánchez, et al.. (1992). University of Wisconsin solution versus crystalloid cardioplegia for human donor heart preservation. Journal of Thoracic and Cardiovascular Surgery. 103(2). 194–199. 62 indexed citations

20.

Giardina, Elsa‐Grace V., Miriam Schneider, & Mark L. Barr. (1990). Myocardial amiodarone and desethylamiodarone concentrations in patients undergoing cardiac transplantation. Journal of the American College of Cardiology. 16(4). 943–947. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact